SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-15-000686
Filing Date
2015-02-17
Accepted
2015-02-17 13:31:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 CONSONANCE CAPITAL MANAGEMENT LP furxa1_21315.htm SC 13G/A 38115
  Complete submission text file 0001085146-15-000686.txt   39776
Mailing Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560
Business Address 3900 PARAMOUNT PARKWAY SUITE 150 MORRISVILLE NC 27560 919-456-7800
Furiex Pharmaceuticals, Inc. (Subject) CIK: 0001484478 (see all company filings)

IRS No.: 271197863 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85529 | Film No.: 15620561
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019
Business Address 1370 AVENUE OF THE AMERICAS SUITE 3301 NEW YORK NY 10019 212.660-8062
Consonance Capital Management LP (Filed by) CIK: 0001544773 (see all company filings)

IRS No.: 260294313 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A